Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b559cd06d1a2234d084caaf821a3fa6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31be08883fd72fb4cf9e0294d950f002 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate |
2005-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf106e8b1bfe9b451d819d064f116f70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e02ddeab5abd6313402c40e270a8207 |
publicationDate |
2012-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2415481-A2 |
titleOfInvention |
Immunostimulatory viral RNA oligonucleotides |
abstract |
An immunostimulatory composition comprising a 4-mer RNA motif provided as 5'-N 1 -U-U-G-U-N 2 -3', wherein N 1 and N 2 independently are RNA sequences 0-10 nucleotides long. The 4-mer motif is sufficient to confer new and altered immunostimulatory properties in new and existing oligonucleotides. Also provided are methods of stimulating an immune response comprising administering said immunostimulatory 4-mer motif composition. |
priorityDate |
2004-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |